Introduction
The recent 15% drop in Advair inhaler sales volume for GSK is a significant concern that requires thorough investigation. This analysis will systematically identify, validate, and address the root cause while considering both immediate and long-term implications for the product and company.
This analysis follows a structured approach covering issue identification, hypothesis generation, validation, and solution development.
Step 1
Clarifying Questions (3 minutes)
Why it matters: Regional differences could point to localized issues or market-specific challenges. Expected answer: Variations across regions. Impact on approach: Focus on region-specific factors if variations exist.
Why it matters: Patent expiration often leads to increased competition and price pressure. Expected answer: Patent expired within the last year. Impact on approach: Investigate market share changes and pricing strategies.
Why it matters: Changes in coverage can significantly impact patient access and sales volume. Expected answer: Some changes in coverage have occurred. Impact on approach: Analyze impact of policy changes on prescription patterns.
Why it matters: New or strengthened competition could explain the sales volume decrease. Expected answer: Some competitive movement in the market. Impact on approach: Assess competitive landscape and GSK's market positioning.
Why it matters: Internal changes could inadvertently impact product availability or perception. Expected answer: Some internal changes have occurred. Impact on approach: Investigate impact of internal changes on product performance.
Practice similar questions
Subscribe to access the full answer